BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25389994)

  • 1. Automated immunoassays for the autoantibodies to carbamylated or citrullinated telopeptides of type I and II collagens.
    Häyrynen J; Kärkkäinen M; Kononoff A; Arstila L; Elfving P; Niinisalo H; Savolainen E; Kautiainen H; Risteli J; Kaipiainen-Seppänen O; Koivula MK
    Clin Chem Lab Med; 2015 Aug; 53(9):1375-80. PubMed ID: 25389994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides.
    Turunen S; Hannonen P; Koivula MK; Risteli L; Risteli J
    Arthritis Res Ther; 2015 Jan; 17(1):2. PubMed ID: 25573503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis.
    Koivula MK; Heliövaara M; Rissanen H; Palosuo T; Knekt P; Immonen H; Risteli J
    Ann Rheum Dis; 2012 Oct; 71(10):1666-70. PubMed ID: 22419777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis.
    Koivula MK; Ramberg J; Aman S; Karjalainen A; Hakala M; Risteli J
    Clin Chem Lab Med; 2005; 43(12):1400-5. PubMed ID: 16309380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis.
    Koivula MK; Heliövaara M; Ramberg J; Knekt P; Rissanen H; Palosuo T; Risteli J
    Ann Rheum Dis; 2007 Nov; 66(11):1450-5. PubMed ID: 17472989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
    Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
    Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ureido group-specific antibodies are induced in rabbits immunized with citrulline- or homocitrulline-containing antigens.
    Turunen S; Koivula MK; Risteli L; Risteli J
    Autoimmunity; 2016 Nov; 49(7):459-465. PubMed ID: 27098309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis.
    Koivula MK; Aman S; Alasaarela E; Karjalainen A; Hakala M; Risteli J
    Rheumatology (Oxford); 2006 Nov; 45(11):1364-9. PubMed ID: 16632481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity to citrullinated type II collagen in rheumatoid arthritis.
    Yoshida M; Tsuji M; Kurosaka D; Kurosaka D; Yasuda J; Ito Y; Nishizawa T; Yamada A
    Mod Rheumatol; 2006; 16(5):276-81. PubMed ID: 17039307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series.
    Koivula MK; Savolainen E; Kaipiainen-Seppänen O; Kautiainen H; Luosujärvi R; Hakala M; Risteli J
    Rheumatology (Oxford); 2008 May; 47(5):656-9. PubMed ID: 18356174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue.
    Turunen S; Huhtakangas J; Nousiainen T; Valkealahti M; Melkko J; Risteli J; Lehenkari P
    Arthritis Res Ther; 2016 Oct; 18(1):239. PubMed ID: 27765067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides.
    Scinocca M; Bell DA; Racapé M; Joseph R; Shaw G; McCormick JK; Gladman DD; Pope J; Barra L; Cairns E
    J Rheumatol; 2014 Feb; 41(2):270-9. PubMed ID: 24429169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis.
    Turunen S; Koivula MK; Melkko J; Alasaarela E; Lehenkari P; Risteli J
    J Transl Med; 2013 Sep; 11():224. PubMed ID: 24060405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].
    Tian X; Bi LQ; Li ZG
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
    Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
    Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides.
    Christensen AF; Hørslev-Petersen K; Christgau S; Lindegaard HM; Lottenburger T; Junker K; Hetland ML; Stengaard-Pedersen K; Jacobsen S; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Heegaard NH; Vestergaard A; Jurik AG; Ostergaard M; Junker P
    J Rheumatol; 2010 Jun; 37(6):1113-20. PubMed ID: 20436079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
    Burkhardt H; Sehnert B; Bockermann R; Engström A; Kalden JR; Holmdahl R
    Eur J Immunol; 2005 May; 35(5):1643-52. PubMed ID: 15832289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis.
    Cook AD; Gray R; Ramshaw J; Mackay IR; Rowley MJ
    Arthritis Res Ther; 2004; 6(5):R477-83. PubMed ID: 15380047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies.
    Cornillet M; Sebbag M; Verrouil E; Magyar A; Babos F; Ruyssen-Witrand A; Hudecz F; Cantagrel A; Serre G; Nogueira L
    Ann Rheum Dis; 2014 Jun; 73(6):1246-52. PubMed ID: 23636655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.